Healthcare & Life Sciences
Ukko
United Stateswww.ukko.us/
Ukko is a series b startup based in Israel. 2 investors tracked.
Activeseries-b
series-b
Stage
2020
Founded
2
Investors
About Ukko
Based in the United States, Ukko is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Ukko develops immuno-therapeutics for food allergies using an AI-driven protein design platform to create modified allergens that retrain the immune system to tolerate them without triggering allergic reactions.
Explore Ukko's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.